User profiles for "author:George Burke"

George Burke

- Verified email at miami.edu - Cited by 14230

George Burke

- Verified email at med.miami.edu - Cited by 4348

Beyond self-actualization

L Greene, G Burke - Journal of health and human services …, 2007 - journals.sagepub.com
“Maslow's Hierarchy of Needs” is a diagram etched in the minds of most business and social
science majors and many practitioners. It is much like a mantra and has been widely …

Clinical operational tolerance after renal transplantation: current status and future challenges

G Orlando, P Hematti, RJ Stratta, GW Burke III… - Annals of …, 2010 - journals.lww.com
In solid organ transplantation, the achievement of an immunosuppression (IS)-free state
[also referred to as clinical operational tolerance (COT)] represents the ultimate goal …

Meaning in motivation: does your organization need an inner life?

EE Morrison, GC Burke III… - Journal of Health and …, 2007 - journals.sagepub.com
Leaders of health care organizations are increasingly interested in ways to attract, retain,
and gain commitment from their employees. This interest is created in part because high …

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

C Wei, S El Hindi, J Li, A Fornoni, N Goes… - Nature medicine, 2011 - nature.com
Focal segmental glomerulosclerosis (FSGS) is a cause of proteinuric kidney disease,
compromising both native and transplanted kidneys. Treatment is limited because of a …

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis

A Fornoni, J Sageshima, C Wei… - Science translational …, 2011 - science.org
Focal segmental glomerulosclerosis (FSGS) is a glomerular disease characterized by
proteinuria, progression to end-stage renal disease, and recurrence of proteinuria after …

[HTML][HTML] Abatacept in B7-1–positive proteinuric kidney disease

CC Yu, A Fornoni, A Weins, S Hakroush… - … England Journal of …, 2013 - Mass Medical Soc
Abatacept (cytotoxic T-lymphocyte–associated antigen 4–immunoglobulin fusion protein
[CTLA-4–Ig]) is a costimulatory inhibitor that targets B7-1 (CD80). The present report …

Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation

S Tamura, T Kato, M Berho, EP Misiakos… - Archives of …, 2001 - jamanetwork.com
Hypothesis Histological grade of hepatocellular carcinoma (HCC) is an important prognostic
factor affecting patient survival after orthotopic liver transplantation (OLT). Design …

Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic …

F Vendrame, A Pileggi, E Laughlin, G Allende… - Diabetes, 2010 - Am Diabetes Assoc
OBJECTIVE To investigate if recurrent autoimmunity explained hyperglycemia and C-
peptide loss in three immunosuppressed simultaneous pancreas-kidney (SPK) transplant …

A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation

M Delville, TK Sigdel, C Wei, J Li, SC Hsieh… - Science translational …, 2014 - science.org
Recurrence of focal segmental glomerulosclerosis (rFSGS) after kidney transplantation is a
cause of accelerated graft loss. To evaluate pathogenic antibodies (Abs) in rFSGS, we …

A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune …

G Ciancio, GW Burke, JJ Gaynor, MR Carreno… - …, 2005 - journals.lww.com
Background. New trends in immunosuppression in clinical transplantation include the use of
antibody induction agents in protocols that emphasize reduction or avoidance of steroids …